SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership
SEC Accession No. 0001193125-15-104528
Filing Date
2015-03-25
Accepted
2015-03-25 11:55:54
Documents
6
Filing Date Changed
2015-03-25
Group Members
PS MANAGEMENT GP, LLCWILLIAM A. ACKMAN

Document Format Files

Seq Description Document Type Size
1 SC 13D d892712dsc13d.htm SC 13D 76331
2 EX-99.1 d892712dex991.htm EX-99.1 6267
3 EX-99.2 d892712dex992.htm EX-99.2 234117
4 EX-99.3 d892712dex993.htm EX-99.3 17021
5 EX-99.4 d892712dex994.htm EX-99.4 30019
6 GRAPHIC g892712ex99_3sig.jpg GRAPHIC 1251
  Complete submission text file 0001193125-15-104528.txt   367451
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Subject) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-45947 | Film No.: 15723922
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019 212-813-3700
Pershing Square Capital Management, L.P. (Filed by) CIK: 0001336528 (see all company filings)

IRS No.: 383694136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D